Skip to content
10-Q

Quarterly Report

NOBLE MEDICAL TECHNOLOGIES, INC.

0001144204-11-066267

← back to feed
Filed
Nov 21, 2011 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2011 · Nov 21, 2011 4.19M sh
Operating Cash Flow Q3 2011 · Sep 30, 2011 −$683.93K
Operating Cash Flow Q3 2011 · Sep 30, 2010 −$15K
Stockholders Equity Q3 2011 · Sep 30, 2011 −$1.19M
Stockholders Equity Q3 2011 · Dec 31, 2010 $70.17K
Stockholders Equity Q3 2011 · Dec 31, 2009 −$9.54K
Current Liabilities Q3 2011 · Sep 30, 2011 $1.22M
Current Liabilities Q3 2011 · Dec 31, 2010 $468.72K
Total Liabilities Q3 2011 · Sep 30, 2011 $1.47M
Total Liabilities Q3 2011 · Dec 31, 2010 $468.72K
Current Assets Q3 2011 · Sep 30, 2011 $267.57K
Current Assets Q3 2011 · Dec 31, 2010 $527.99K
Total Assets Q3 2011 · Sep 30, 2011 $276.75K
Total Assets Q3 2011 · Dec 31, 2010 $538.89K
Sga Expense Q3 2011 · Sep 30, 2011 $15.35K
Sga Expense Q3 2011 · Sep 30, 2011 $72.9K
Net Income Q3 2011 · Sep 30, 2011 −$460.91K
Net Income Q3 2011 · Sep 30, 2011 −$1.61M
Net Income Q3 2011 · Dec 31, 2010 −$160.29K
Net Income Q3 2011 · Sep 30, 2010 −$7.5K
Net Income Q3 2011 · Sep 30, 2010 −$22.29K
Operating Income Q3 2011 · Sep 30, 2011 −$342.08K
Operating Income Q3 2011 · Sep 30, 2011 −$1.02M
Operating Income Q3 2011 · Sep 30, 2010 −$7.5K
Operating Income Q3 2011 · Sep 30, 2010 −$22.29K